Institutional investors purchased a net $156.0 thousand shares of MBOT during the quarter ended December 2017. This may signal that the smart money is gaining interest in this company as the 5.52% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CITADEL ADVISORS LLC Bought 76.3 Thousand shares of Microbot Medical Inc
TWO SIGMA SECURITIES LLC Bought 36.0 Thousand shares of Microbot Medical Inc
FSC SECURITIES CORP. Bought 26.0 Thousand shares of Microbot Medical Inc